NCT03229655

Brief Summary

Prospective, randomized comparison of the incremental dilation and stent exchange vs. sequential stent addition approaches for management of anastomotic biliary strictures will facilitate optimal management of patients who develop anastomotic biliary strictures after liver transplantation.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2017

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 30, 2017

Completed
25 days until next milestone

First Posted

Study publicly available on registry

July 25, 2017

Completed
1 month until next milestone

Study Start

First participant enrolled

September 1, 2017

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2020

Completed
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2022

Completed
Last Updated

September 11, 2018

Status Verified

September 1, 2018

Enrollment Period

3 years

First QC Date

June 30, 2017

Last Update Submit

September 8, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • Anastomotic biliary stricture resolution

    Fluoroscopic (on ERCP image) resolution of stricture at the time of final study ERCP when all stents are removed

    Immediately following final ERCP with stent removal

Secondary Outcomes (4)

  • Fluoroscopy Parameters

    1 day

  • Adverse Events

    1 week

  • Sustained resolution of anastomotic stricture for 6 months

    6 months after final study ERCP with stent removal

  • Sustained resolution of anastomotic stricture for 12 months

    12 months after final study ERCP with stent removal

Study Arms (2)

Sequential stent addition

EXPERIMENTAL

ERCP with sphincterotomy and stent placement is initially performed, then additional stents are placed across the stricture during sequential ERCPs, without stent removal/exchange or stricture dilation.

Procedure: Protocol for increasing number of stents across the anastomosis

Incremental Dilation & Stent Exchange

ACTIVE COMPARATOR

ERCP with sphincterotomy and stent placement is initially performed, with subsequent ERCPs involving removal of previously placed stents, stricture dilation and balloon sweeps to extract stone debris/sludge.

Procedure: Protocol for increasing number of stents across the anastomosis

Interventions

Sequential placement of straight plastic biliary stents across the duct-to-duct anastomosis without dilation or stent exchange. Multiple ERCPs will be performed with addition of a single stent at each ERCP until the final ERCP when all stents will be removed.

Incremental Dilation & Stent ExchangeSequential stent addition

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18 and older
  • Clinical concern for anastomotic biliary stricture following liver transplantation (as determined by the referring transplant hepatologist)
  • Willing and able to comply with the study procedures and provide written informed consent to participate in the study.

You may not qualify if:

  • Age \<18
  • Potentially vulnerable subjects including, homeless people, pregnant females, employees and students.
  • Complex post-surgical anatomy e.g. Choledochojejunostomy, Billroth type II anatomy, Roux-en-Y-gastrojejunostomy
  • Participation in another investigational study that may directly or indirectly affect the results of this study within 30 days prior to the initial visit
  • Other biliary process which accounts for patient's abnormal liver function studies/imaging (i.e. significant non-anastomotic biliary stricture).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Stanford University Medical Center

Stanford, California, 94305, United States

RECRUITING

MeSH Terms

Interventions

Clinical Protocols

Intervention Hierarchy (Ancestors)

TherapeuticsEpidemiologic Study CharacteristicsHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and Evaluation

Central Study Contacts

Subhas Banerjee, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Randomized prospective study
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor of Medicine, Division of Gastroenterology

Study Record Dates

First Submitted

June 30, 2017

First Posted

July 25, 2017

Study Start

September 1, 2017

Primary Completion

September 1, 2020

Study Completion

September 1, 2022

Last Updated

September 11, 2018

Record last verified: 2018-09

Data Sharing

IPD Sharing
Will not share

Locations